Pluri Share Price

Pluri Share Price

NASDAQ: PLUR | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Pluri Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$0.87 - $3.94
Volume
N/A
Average Traded
N/A

Pluri Share Price Chart

Line chart of the Pluri price trend over the selected period. The price rose overall, ranging from 1.01 to 1.01, ending at 1.01.
$0.00$0.00
L
Show Current Price
H

Pluri Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.97
Revenue (TTM)
$1.02B
Return On Equity (TTM)
137.64%
Profit Margin
-2335.29%
Debt to Equity
-1.34
Quarterly Earnings Growth YoY
-58.87%

Pluri Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.20$0.17$0.34$0.76
Net Profit-$6.54-$5.55-$5.88-$10.39
Net Profit Margin-3270.00%-3264.71%-1729.41%-1367.11%
Income ChangeN/A15.14%-5.95%-76.70%

Pluri Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.29$0.33$1.34$1.02
Net Profit-$28.32-$20.89-$22.58-$23.82
Net Profit Margin-9765.52%-6330.30%-1685.07%-2335.29%
Income ChangeN/A26.24%-8.09%-5.49%

Pluri Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets16.1516.598.429.39
Current Assets8.7322.131.1141.41
Total Assets24.8838.6839.5350.8
Non Current Liabilities7.557.2229.6629.88
Current Liabilities32.7232.334.455.62
Total Liabilities40.2739.5534.1135.5
Shareholders' Equity-15.39-0.875.4215.3

Pluri Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-19.59-18.21-18.02-23.69
Investing9.98.0310.589.7
Financing7.049.538.848.02

Corporate Actions

Split
Ex-date: 01 Apr 2024

Split
Ex-date: 25 Jul 2019

About Pluri

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Pluri Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.24
$1.01
-17.89%
Oct 2026
$0.87
$1.23
+16.04%
Sep 2026
$1.29
$1.06
-29.33%
Aug 2026
$1.83
$1.50
-3.23%
Jul 2026
$2.19
$1.55
-28.24%
Jun 2026
$2.47
$2.16
-14.46%
May 2026
$3.40
$2.52
-24.63%
Apr 2026
$3.38
$3.35
+9.12%
Mar 2026
$3.71
$3.07
-16.58%
Feb 2026
$3.35
$3.68
+8.55%
Jan 2026
$3.02
$3.39
+12.62%
Dec 2025
$3.50
$3.01
-20.58%

Pluri Share Price FAQs